Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02939573 · ClinicalTrials.gov registry record · Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

A Phase 2 study of IgA Vasculitis and Primary Cutaneous Vasculitis, sponsored by University of Pennsylvania.

Recruiting
Registry status
Phase 2
Development phase
90
Enrollment target
16
Study locations

NCT02939573: Recruiting Phase 2 study of IgA Vasculitis and Primary Cutaneous Vasculitis, sponsored by University of Pennsylvania.

NCT02939573 is a Phase 2 study of IgA Vasculitis and Primary Cutaneous Vasculitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 90 participants, below the 248-participant average among 5 other IgA Vasculitis trials with a reported enrollment target (64% lower). The trial reports 16 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02939573, a Phase 2 study of IgA Vasculitis and Primary Cutaneous Vasculitis, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
Phase 2
Development phase
90 participants
Enrollment target
16
Study locations

Study Summary

Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis.

Primary Outcome

Compare response to therapies.

Conditions Studied

IgA Vasculitis Primary Cutaneous Vasculitis Cutaneous Polyarteritis Nodosa Henoch-Schönlein Purpura

Interventions

  • DRUG Colchicine
  • DRUG Dapsone
  • DRUG Azathioprine

Study Locations (16)

New York

  • Northwell Health - Lake Success
  • Hospital for Special Surgery - New York

Pennsylvania

  • Penn State Hershey Medical Center - Hershey
  • University of Pennsylvania - Philadelphia

Ontario

  • St. Joseph's Healthcare - Hamilton
  • University of Toronto Mount Sinai Hospital - Toronto

Kansas

  • University of Kansas Medical Center - Kansas City

Massachusetts

  • Boston University School of Medicine - Boston

Minnesota

  • Mayo Clinic - Rochester

Ohio

  • Cleveland Clinic - Cleveland

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2017-01-01
Est. Completion 2028-12-31
Phase Phase 2
University of Pennsylvania

1,423 total trials

What NCT02939573 shows while recruiting

NCT02939573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 248-participant average among 5 other IgA Vasculitis trials with a reported enrollment target (64% lower).

The record links to 4 conditions, with IgA Vasculitis appearing as the primary indexed condition, and to 3 interventions - of which Colchicine is the first listed.

NCT02939573 lists 16 locations in 13 states (New York, Pennsylvania, Ontario).

Frequently Asked Questions

What is clinical trial NCT02939573 about?

NCT02939573 is a clinical study titled "A Randomized Multicenter Study for Isolated Skin Vasculitis". Multi-center sequential multiple assignment randomized trial comparing the effectiveness of three different standard of care treatment options for patients with isolated skin vasculitis.

What is the current status of trial NCT02939573?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2017-01-01. Estimated completion is 2028-12-31.

What conditions does trial NCT02939573 study?

This clinical trial studies the following conditions: IgA Vasculitis, Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa, Henoch-Schönlein Purpura.

What interventions are being tested in trial NCT02939573?

The interventions under investigation include: Colchicine (DRUG), Dapsone (DRUG), Azathioprine (DRUG).

Who is sponsoring clinical trial NCT02939573?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02939573 being conducted?

This trial has 16 study locations across Kansas, Massachusetts, Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for IgA Vasculitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

  • NCT03263572 · 90 participants · Phase 2

    Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT02939573

Source: ClinicalTrials.gov NCT02939573, the US trial registry maintained by the National Library of Medicine. NCT02939573 (small enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.